| Date | Ref. No. | Patent No. | Title |
| 11/4/2009 | E-248-2002/0 | | Methods and Compositions for the Diagnosis of Neuroendocrine Lung Cancer |
| 10/27/2009 | E-295-2009/0 | | Prediction of Immune Response Outcomes to Keyhole Limpet Hemocyanin (KLH) Treatment |
| 10/12/2009 | E-328-2007/0 | | Identification of Persons Likely to Benefit from Statin Mediated Cancer Prevention by Pharmacogenetics |
| 10/12/2009 | E-163-2009/0 | | B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia |
| 9/9/2009 | E-089-2009/0 | | Immunogenic Tumor-associated Antigen SPANX-B for Selective Cancer Immunotherapy |
| 8/14/2009 | E-063-2008/1 | | Nanoparticles for Imaging and Treatment of Brain Tumors |
| 8/12/2009 | E-118-2009/0 | | Novel Diagnostic and Therapeutic Biomarkers for Squamous Cell Carcinomas |
| 8/11/2009 | E-058-2009/0 | | Development of a New Carbohydrate Antibody to GalNac1-3Gal |
| 8/11/2009 | E-207-2009/0 | | Superior Method of Preparing Dendrimers for Use as Magnetic Resonance Imaging (MRI) Contrast Agents |
| 7/2/2009 | E-042-2009/0 | | Immunogenic Peptide from NGEP Protein for Developing Prostate Cancer Vaccines |
| 6/23/2009 | E-314-2008/0 | | Inflammatory Genes and MicroRNA-21 as Biomarkers for Colon Cancer Prognosis |
| 6/11/2009 | E-086-2007/0 | | An Imaging Radiotracer for the Noninvasive Detection of HER2-positive Tumors |
| 5/28/2009 | E-340-2008/0 | | Methods for Identifying Breast Cancer Patients for Therapy with mTOR Inhibitors |
| 5/28/2009 | E-053-2009/0 | | Diagnostic Markers for Melanoma |
| 5/28/2009 | E-023-2009/0 | | Genomics-based Diagnostic Assay for Cancer |
| 5/15/2009 | E-317-2008/0 | | Identification of Renal Cell Carcinoma Biomarkers |
| 5/11/2009 | E-304-2006/0 | | Enhanced Function of Gene Modified T-Cells: Identification of T-Cell Receptors (TCR) with Altered Amino Acid Sequence |
| 5/5/2009 | E-179-2008/0 | | Salcut-NH2: A Novel Target for Development of Anti-Tumorigenic, Anti-Angiogenic Therapeutics and Diagnostics |
| 5/5/2009 | E-092-2008/0 | | Novel Oligonucleotides for Treatment of Human Cancer |
| 5/4/2009 | E-154-2004/0 | | Creation and Characterization of Carcinogen-Altered Mouse Epidermal Cell Lines |
| 5/4/2009 | E-257-2004/0 | | Modulating Expression of the Metastasis Suppressor MxA |
| 5/4/2009 | E-223-2006/1
E-284-2008/0 | | Small-Molecule TSH Receptor Modulators for Diagnosis and Treatment of Thyroid Disease and Cancer |
| 5/4/2009 | E-025-2009/0 | | Ratio Based Biomarkers for the Prediction of Cancer Survival |
| 3/23/2009 | E-314-2006/0 | | Increased Image Quality for Early Colon Polyp Detection |
| 2/2/2009 | E-215-2008/0 | | Prognostic Test for Breast Cancer Based on a 12 Gene Expression Signature |
| 12/1/2008 | E-283-2008/0 | | Method for Detection of Cancer Based on Spatial Genome Organization in the Cell Nucleus |
| 11/1/2008 | E-256-2008/0 | | Gene Expression Profiling for Prognosis of a Non-Hodgkin Lymphoma |
| 11/1/2008 | E-166-2007/0 | | Discovery of and Use of Fragments of DOC1 as Antiangiogenic and Antitumor Therapy |
| 11/1/2008 | E-256-1999/0 | | Methods for Accurately Measuring and Regulating Bound Adrenomedullin |
| 10/1/2008 | E-263-2006/1 | | Methods of Determining the Prognosis of an Adenocarcinoma |
| 10/1/2008 | E-065-2008/0 | | Association of the ECHDCI/RNF146 Gene Region on Human Chromosome 6q with Breast Cancer Risk and Protection |
| 9/1/2008 | E-175-2008/0 | | Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors |
| 9/1/2008 | E-139-1999/0 | 7,081,518 | A Novel Recombinant Immunotoxin SS1P (anti-mesothelin dsFv-PE38): A Therapeutic Treatment for Lung Cancer and Other Mesothelin Expressing Cancers |
| 9/1/2008 | E-147-2008/0 | | Cyclized NGR Peptide for Tumor Targeting |
| 8/1/2008 | E-285-2006/2 | | New Tumor Endothelial Markers: Genes that Distinguish Physiological and Pathological Angiogenesis |
| 8/1/2008 | E-093-2007/0 | | Extracellular Matrix Gene Chips to Detect Metastatic Tumors |
| 8/1/2008 | E-062-1996/0
E-099-1996/0
E-154-1998/0
E-200-1990/3
E-200-1990/4
E-256-1998/0
E-256-1998/1
E-259-1994/3
E-259-1994/4
E-260-1994/1 | 6,001,349
6,045,802
6,165,460
6,319,496
6,548,068
6,756,038
6,893,869
6,946,133
6,969,609
7,118,738
7,211,432
7,368,116
7,410,644
7,547,773
7,598,225 | Enhanced T-cell Activation by Costimulation: A Potentially Novel Approach for the Prevention and/or Therapy of Cancer (Excluding Prostate Diseases and Melanoma) and for Infectious Diseases |
| 8/1/2008 | E-262-2000/0
E-262-2000/1 | 6,977,241
7,425,537 | SH2 Domain Binding Inhibitors |
| 7/1/2008 | E-282-2007/0 | | TGF-beta Gene Expression Signature in Cancer Prognosis |
| 7/1/2008 | E-091-2008/0 | | Method for Detection and Quantification of PLK1 Expression and Activity |
| 7/1/2008 | E-263-2004/0 | | A New Pot1 Variant Gene as a Diagnostic Biomarker for Hereditary Non-polyposis Colorectal Cancer |
| 7/1/2008 | E-071-2003/0 | 7,316,903 | Rapid and Sensitive Detection of Nucleic Acid Sequence Variations |
| 7/1/2008 | E-203-2008/0 | | T-Cell Enumeration Using Dried Blood Spots as a Surrogate for CD4+ T-Cell Counts to Monitor HIV+ Patients |
| 6/1/2008 | E-317-2007/0 | | Novel Fluorinated Dmt-Tic Analogues for Use as PET Radiotracers |
| 5/1/2008 | E-080-2008/0 | | Human and Improved Murine Monoclonal Antibodies Against CD22 |
| 5/1/2008 | E-079-2008/0 | | Human Monoclonal Antibody Against Mesothelin |
| 5/1/2008 | E-192-2007/0 | | A Molecular Grading System for Ductal Carcinoma In Situ (DCIS) of the Breast: A New Molecular Diagnostics to Determine Disease Stages of DCIS |
| 5/1/2008 | E-056-2007/0 | | Microarray Binding Sensors Using Carbon Nanotube Transistors |
| 5/1/2008 | E-281-2007/0 | | Multicolored Fluorescent Cell Lines for High-Throughput Angiogenesis and Cytotoxicity Screening |
| 5/1/2008 | E-265-2007/0 | | Telomerase Suppressor Compositions and Methods for Diagnosis and Treatment of Cancer |
| 2/1/2008 | E-183-1999/0 | 7,256,260 | Human p53 Mutations and a Genetic System in Yeast for Functional Identification of Human p53 Mutations |
| 2/1/2008 | E-137-2006/0
E-137-2006/1 | | Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Doxorubicin Cancer Therapy |
| 1/1/2008 | E-084-1991/1 | 3715313
6,274,134
684806 | Antibodies and Polypeptides Specific to AAMP-1: Diagnostic and Therapeutic Uses Thereof |
| 1/1/2008 | E-008-2008/0 | | Diagnosis and Treatment of Barrett's Esophagus and Associated Esophageal Adenocarcinoma |
| 12/1/2007 | E-194-2007/0 | | Tri-functional Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging |
| 12/1/2007 | E-157-2007/0 | | Nanoparticles For Imaging: Targeted Nanoparticles That Can Be Imaged Through Magnetic Resonance, Optical, And Radioisotope Imaging |
| 11/1/2007 | E-177-2006/0 | 7,553,936 | A Novel, Inhibitory Platelet Surface Protein (TREM Like Transcript, TLT-1): New Target for the Treatment of Cancer, Infectious Diseases, Cardiac Diseases, and Platelet-Associated Disorders |
| 11/1/2007 | E-061-2007/0 | | Diagnostic Ovarian Cancer Biomarkers |
| 11/1/2007 | E-139-1999/0 | 7,081,518 | A Clinically Proven Therapeutic Treatment and Diagnostic Tool for Mesothelin Expressing Cancers: A Novel Recombinant Immunotoxin SS1P (anti-mesothelin dsFv-PE38) |
| 11/1/2007 | E-083-2007/0 | | SLCO1B3 Genotyping to Predict a Survival Prognosis of Prostate Cancer |
| 11/1/2007 | E-232-1995/0
E-232-1995/1 | 5,658,744
5,965,366 | A New Method for Determining Level of Immunosuppression in Humans |
| 10/1/2007 | E-064-2005/0 | | Biomarkers for Tissue Status |
| 9/1/2007 | E-226-2006/0 | | New Synthetic Variants of 2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriamine Pentaacetic Acid (1B4M-DTPA): Novel Macromolecular MRI Contrast Agents |
| 9/1/2007 | E-272-1998/0 | 6,790,948
7,431,926 | Tumor Suppressor Genes |
| 8/1/2007 | E-028-1999/0 | 7,399,827 | Diagnostic and Therapeutic Methods of Detecting and Treating Cancers of Reproductive Tissues |
| 8/1/2007 | E-215-2007/0 | | Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells |
| 8/1/2007 | E-081-2004/2 | | Serum Autoantibody for Cancer Diagnostics |
| 7/1/2007 | E-118-2005/0 | | A Gene Therapy to Treat Lung Cancer |
| 6/1/2007 | E-117-2006/0 | | Diagnostic and Therapeutic Use of Brother of the Regulator of Imprinted Sites (BORIS) Alternative Splice Forms |
| 6/1/2007 | E-042-1998/0 | 6,897,018
7,534,565 | DLC-1 Gene Deleted in Cancers |
| 6/1/2007 | E-060-2007/0 | | A Gene Expression Profile that Predicts Ovarian Cancer Patient Response to Chemotherapy |
| 6/1/2007 | E-138-2000/0 | 7,279,294 | Tumor Markers in Ovarian Cancer |
| 5/1/2007 | E-082-2005/0
E-082-2005/2 | | Sipa-Gene and Sipa-1 Inhibitor for the Diagnosis and Treatment of Metastatic Cancer |
| 5/1/2007 | E-018-2005/2 | | Diagnosing and Treating Cancer Using beta-Catenin Splice Variants |
| 5/1/2007 | E-287-2004/1 | | Novel Diagnostics and Therapeutics for Various Hematologic Malignancies: Monoclonal Antibodies to Members of Fc receptor-like (FCRL) Proteins |
| 5/1/2007 | E-070-2005/0 | | Inhibitors of Ubiquitin E1 |
| 5/1/2007 | D-001-1996/1
D-001-2006/0
D-003-1992/2
D-003-1992/3
D-004-1992/0
D-004-1992/1
E-259-1998/2 | 5,472,693
5,877,291
5,892,020
6,051,225
6,071,515
6,207,815
6,329,507
6,348,581
6,737,060
6,737,061
6,752,990
6,753,152
6,753,420
6,818,749
628078
7,256,004 | Humanized Anti-Carcinoma CC49 Monoclonal Antibodies |
| 5/1/2007 | E-062-1996/0
E-099-1996/0
E-154-1998/0
E-200-1990/3
E-200-1990/4
E-256-1998/0
E-256-1998/1
E-259-1994/3
E-259-1994/4
E-260-1994/1 | 6,001,349
6,045,802
6,165,460
6,319,496
6,548,068
6,756,038
6,893,869
6,946,133
6,969,609
7,118,738
7,211,432
7,368,116
7,410,644
7,547,773
7,598,225 | Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases |
| 3/1/2007 | E-290-2000/0 | 7,078,176 | A Novel, Clinically Validated, Efficient and Non-Invasive In Vitro Diagnostic and Prognostic Test for Cancer |
| 2/1/2007 | E-317-2004/1 | | Metal Chelators and Target-Moiety Complexes for Imaging |
| 1/1/2007 | E-132-2006/0
E-132-2006/1
E-132-2006/2 | | A New Method for Improving the Therapeutic Efficacy of L-Asparaginase in Multiple Types of Cancer |
| 1/1/2007 | E-293-2006/0 | | Megakaryocyte Potentiation Factor as a New Serum Tumor Marker for Mesothelioma |
| 12/1/2006 | E-125-2006/1 | | Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor |
| 10/1/2006 | E-027-2006/0 | | PDE11A as a Novel Therapeutic Target for Inherited Form of Cushing Syndrome and Endocrine Tumors |
| 9/1/2006 | E-207-2006/0 | | Novel Monoclonal Antibody Microarray |
| 9/1/2006 | E-265-1997/0 | 7,084,239 | Cancer Peptides of NY-ESO-1/CAG-3 |
| 8/1/2006 | E-201-2006/1 | | Diagnostic and Therapeutic Strategies for Metastatic Hepatocellular Carcinoma by Targeting Osteopontin |
| 8/1/2006 | E-086-2006/0 | | Hybrid T-Cell Receptors for the Development of Improved Vaccines |
| 6/1/2006 | E-091-2004/0 | | Ultrasonic Waves with Nanovessels or Tethered Nanotube/Monoclonal Antibody Composites for Cancer Therapy |
| 6/1/2006 | E-090-2004/0 | | Radio-Activated Boron-Nitride Nanotube-Antibody Conjugates for Cancer Therapy and Diagnostics |
| 6/1/2006 | E-122-2006/0 | | Agonist Epitopes for Renal Cell Carcinoma |
| 6/1/2006 | E-325-2003/0 | | Biofunctionalized Quantum Dots for Biological Imaging |
| 5/1/2006 | E-139-2005/0 | | Identification of a Novel Folliculin Interacting Protein, FNIP-1 |
| 5/1/2006 | E-261-2005/0
E-261-2005/1 | | Sensitive Antibody-based Assay for the Measurement of c-Met Concentration Shed in Bodily Fluids Useful in the Diagnosis and Prognosis of Cancer |
| 4/1/2006 | E-194-2005/0 | | The Medusa™ Sequencer: A Sequencing Machine the Size of a Molecule that Could Sequence RNA in a Living Cell |
| 4/1/2006 | E-195-2005/0 | | Nanoprobes for Detection or Modification of Molecules |
| 3/1/2006 | E-258-2005/0 | | Method for Determining Redox Status of a Tissue |
| 3/1/2006 | E-307-2005/0 | | Use of CYP1B1*3 Genotyping to Predict Survival to Docetaxel Treatment in Androgen-Independent Prostate Cancer |
| 2/1/2006 | E-057-2006/0 | | Autoantibody Screening for Cancer Diagnosis |
| 2/1/2006 | E-106-2005/0 | | Identification of Biomarkers by Serum Protein Profiling |
| 2/1/2006 | E-065-2002/0 | | ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma |
| 12/1/2005 | E-323-2003/0 | 7,589,181 | Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use |
| 12/1/2005 | E-210-2005/0 | | Mitotic Spindle ASPM as a Diagnostic Marker for Neoplasia and Uses Thereof |
| 12/1/2005 | E-142-1990/2 | 5,731,167
6,084,069
6,417,338 | Autotaxin: Motility Stimulating Protein Useful in Cancer Diagnosis and Therapy |
| 12/1/2005 | E-152-2002/0
E-152-2002/1 | | Quantitative Assay of the Angiogenic and Antiangiogenic Activity of a Test Molecule |
| 11/1/2005 | E-217-2005/0 | | Antibodies Against Insulin-Like Growth Factor II and Uses Thereof |
| 11/1/2005 | E-192-2004/0 | | Compositions and Methods for Diagnosis and Treatment of Chemotherapy-Resistant Neoplastic Disease |
| 10/1/2005 | E-266-1994/1 | 6,428,788 | Compositions and Methods of Specifically Targeting Tumors |
| 9/1/2005 | E-124-2004/0
E-124-2004/1
E-124-2004/2 | | Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions |
| 7/1/2005 | E-208-2005/0 | | Anti-CD30 Antibodies that Bind to Intact CD30 but not to Soluble CD30 |
| 7/1/2005 | E-015-2005/0 | | Anti-Mesothelin Antibodies Useful for Immunological Assays |
| 7/1/2005 | E-075-2004/2 | | Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cells |
| 6/1/2005 | E-339-2004/0 | | Framework Residue Substituted Humanized COL-1 Antibodies and Their Use |
| 5/1/2005 | E-041-2005/0 | | Methods for Detecting Progression of Low Grade Cervical Dysplasia |
| 4/1/2005 | E-265-1994/0
E-265-1994/1 | 6,255,105
6,342,392
6,737,251
7,067,635 | Nucleotide and Deduced Amino Acid Sequences of a New Tumor Gene, Int6 |
| 4/1/2005 | E-324-2001/2 | | Selections of Genes and Methods of Using the Same for Diagnosis and for Targeting the Therapy of Select Cancers |
| 4/1/2005 | E-190-2002/2 | 7,485,709 | Identification of Novel Birt-Hogg-Dubé (BHD) Gene |
| 3/1/2005 | E-101-2005/0 | | Karyotypic Complexity as a Determinant of Anti-Cancer Drug Activity |
| 3/1/2005 | E-105-2004/0
E-105-2004/1 | | Minimally Immunogenic Germline Sequence Variants of COL-1 Antibody and Their Use |
| 3/1/2005 | E-108-2004/0
E-234-2003/0 | | Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas |
| 2/1/2005 | E-324-2001/0 | | Methods for Analyzing High Dimensional Data for Classifying, Diagnosing, Prognosticating, and/or Predicting Diseases and Other Biological States |
| 2/1/2005 | E-324-2001/1 | | Selections of Genes |
| 1/1/2005 | E-287-2004/0
E-287-2004/1 | | Mabs to IRTA2 for Use in Diagnosis and Therapy of IRTA-Expressing Cancers |
| 1/1/2005 | E-269-2003/0 | | Composition for Detecting the Response of Rectal Adenocarcinomas to Radiochemotherapy |
| 1/1/2005 | E-123-2001/0
E-124-2001/1 | 7,247,615 | Peptide Agonists of Prostate-Specific Antigen and Uses Thereof |
| 1/1/2005 | E-051-2003/0 | | Recombinant Immunotoxin and Use in Treating Tumors |
| 10/1/2004 | E-059-2004/0 | | Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics |
| 8/1/2004 | E-094-2004/0 | | Pharmacodynamic Assay |
| 6/1/2004 | E-112-1994/0 | 5,652,223
5,981,712
6,790,936 | DNA Encoding CAI Resistance Proteins and Uses Thereof |
| 5/1/2004 | E-027-2004/0 | | Rapid Integration Site Mapping |
| 3/1/2004 | E-338-2003/0 | | Methods for Imaging the Lymphatic System Using Dendrimer-Based Contrast Agents |
| 2/1/2004 | E-046-1991/3 | 6,673,559 | Met Proto-Oncogene and a Method for Predicting Breast Cancer Progression |
| 2/1/2004 | E-049-2003/0 | 7,554,090 | UltraRad – A Method and Probe to Enhance Radiation Delivery |
| 2/1/2004 | E-244-2002/0 | | Glioma-Selective Polypeptides, Alone or Coupled to a Therapeutic/Diagnostic Agent, Compositions Comprising Same, and Uses Thereof |
| 2/1/2004 | E-227-2001/0 | 7,375,206 | Brother of the Regulator of Imprinted Sites (BORIS) |
| 1/1/2004 | E-039-2003/0 | | Combinatorial Therapy for Protein Signaling Diseases |
| 12/1/2003 | E-211-1998/0 | | Methods for Detecting Cancer Cells |
| 11/1/2003 | E-083-2003/0 | | Intracellular Trapping of Radionuclides by Enzyme-Mediated Reduction |
| 11/1/2003 | E-216-2003/0 | | Mouse Lacking the Chemokine Receptor CX3CR1 |
| 11/1/2003 | E-253-2002/0 | | Compositions and Methods for Detecting Abnormal Cell Proliferation |
| 7/1/2003 | E-190-2000/0 | | Methods and Compositions for Inhibiting HIV-Coreceptor Interactions |
| 7/1/2003 | E-320-2002/0
E-320-2002/1 | 7,255,993 | Detection of Mutational Frequency in Human Bone Marrow |
| 6/1/2003 | E-091-2002/0 | 7,329,502 | Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia (CLL) |
| 4/1/2003 | E-233-2002/0 | | Method of Distinguishing Epithelioid Melanoma from Fibroblastoid Melanoma |
| 3/1/2003 | E-138-2001/0 | 7,618,789 | Use of Semenogelin in the Diagnosis, Prognosis, and Treatment of Cancer |
| 3/1/2003 | E-003-1991/0 | 5,948,613 | Methods of Screening for Risk of Cancer Using Human Lactoferrin DNA Probe or Primer |
| 3/1/2003 | E-057-1994/2 | 5,844,075
6,270,778
6,537,560
6,965,017
7,232,887
7,612,044 | gp100 Cancer Antigens |
| 12/1/2002 | E-156-1999/0 | | Pyrimidine Phosphorylase as a Target for Imaging and Therapy |
| 12/1/2002 | E-013-2002/0 | 7,569,673 | Humanized Anti-TAG 72 CC49 for Diagnosis and Therapy of Human Carcinomas |
| 11/1/2002 | E-196-2001/0 | | Use of Interferon-Inducible 2',5'-Oligoadenylate-Dependent RNase in the Diagnosis, Prognosis, and Treatment of Prostate Cancer |
| 9/1/2002 | E-300-2001/0 | 7,432,349 | New Tumor Suppressor Gene, p28ING5 |
| 5/1/2002 | E-225-2001/0 | | MRP8, A Member of the ABC Transporter Superfamily Highly Expressed in Breast Cancer, and Uses Thereof |
| 5/1/2002 | E-344-2001/0 | | The Ovachip: A Clinically Useful cDNA Array for Differential Diagnosis of Ovarian Cancer |
| 1/1/2002 | E-161-2000/0 | | XAGE-1, A Gene Expressed in Multiple Cancers and Uses Thereof |
| 1/1/2002 | E-286-2000/0 | | Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms |
| 1/1/2002 | E-064-2001/0 | 6,951,761 | Parallel Measurements of Multiple Macromolecules Using a Cryoarray |
| 1/1/2002 | E-086-2001/0
E-086-2001/1 | 7,419,957 | Novel Peptides to a Melanoma Antigen and Their Use in Diagnostic and Therapeutic Methods |
| 1/1/2002 | E-002-2001/0 | | Tumor Antigen Homologous to Poly(A) Polymerase |
| 12/1/2001 | E-295-2001/0 | | Imaging of Extracellular Proteases in Cells Using Mutant Anthrax Toxin Protective Antigens |
| 11/1/2001 | E-261-1998/0 | 6,969,614 | Methods and Devices for Isolation and Analysis of Cellular Protein Content |
| 6/1/2001 | E-053-2001/0 | | PRAC & PRAC-Y: Small Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof |
| 5/1/2001 | E-203-1994/0 | 5,693,779 | Production and Use of Anti-Dorsalizing Morphogenetic Protein |
| 3/1/2001 | E-336-1987/1 | 5,693,778 | ARG, A Human Gene Related to but Distinct from ABL Proto-Oncogene |
| 2/1/2001 | E-237-2000/0 | | RASS1: A Novel Tumor Suppressor Gene Activated by Ras to Promote Apoptosis |
| 12/1/2000 | E-100-2000/0 | | Usage of Two Yeast Strains in the Identification of Specific Inhibitors of Polo Kinases |
| 12/1/2000 | E-014-2000/0 | 6,600,018
7,223,853 | Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof |
| 12/1/2000 | E-170-2000/0 | 7,141,661 | NAG-1: A Non-Steroidal Anti-Inflammatory Drug Related Gene Which Has Anti-Tumorigenic Properties |
| 12/1/2000 | E-259-2000/0 | 6,759,525 | Protein Kinase A and the Carney Complex |
| 5/1/2000 | E-173-1998/0 | 6,995,018 | Assay for the Detection of a Variety of Tumors in Biological Specimens |
| 4/1/2000 | E-201-1992/0 | 5,489,525 | Monoclonal Antibody Specific to Prostate Cells |
| 4/1/2000 | E-194-1998/0 | 6,441,156
6,979,724 | Calcium Channel Compositions and Methods of Use Thereof |
| 9/1/1999 | E-112-1999/0 | 7,008,768
7,563,573 | Method For Detecting Radiation Exposure |
| 8/1/1999 | E-011-1998/0 | 6,849,417
7,442,543 | Mammalian Selenoprotein Differentially Expressed in Tumor Cells |
| 7/1/1999 | E-077-1999/0 | 6,623,960
7,524,939 | Monoclonal Antibodies Specific And Inhibitory To Human Cytochrome P450 2C8, 2C9, 2C18 And 2C19 - New Avenues For Drug Discovery |
| 6/1/1999 | E-032-1995/0 | 5,650,627 | Sensitive Assay for Measuring Gallium Levels in Body Tissues and Fluids |
| 5/1/1999 | E-137-1990/0 | 6,221,620 | Monoclonal Antibodies Specific for Human Thymidylate Synthase |
| 4/1/1999 | E-157-1994/1 | 6,787,306
7,402,387 | Method and Composition for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations |
| 3/1/1999 | E-253-1997/0 | 7,226,731 | PB39, A Novel Isolated Complete cDNA Whose Function is Dysregulated in Prostate Cancer |
| 2/1/1999 | E-193-1995/0 | | Methods for Determining the Prognosis of Breast Cancer Using Antibodies Specific for Thymidylate Synthase |
| 1/1/1999 | E-218-1992/0 | 5,580,760
5,734,016 | Novel FUSE-Binding Protein And cDNA |
| 10/1/1997 | E-018-1997/0 | 6,562,589
7,232,890 | AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer |
| 8/1/1997 | E-094-1997/0 | 7,358,347 | MEN1, The Gene For Multiple Endocrine Neoplasia Type 1 |
| 5/1/1997 | E-183-1996/0
E-219-1995/0 | 5,831,016
5,840,839
6,083,703
6,087,110
6,132,980
7,001,600
7,015,312 | Novel Human Cancer Antigen of Tyrosinase-Related Proteins 1 and 2 and Genes Encoding Same |
| 5/1/1997 | E-046-1997/0 | 6,060,253 | Agents That Bind To And Inhibit Human Cytochrome P450 2D6 |
| 11/1/1996 | E-088-1996/0 | | Point Mutated ras Peptides for the Generation of CD8+ Cytotoxic T Lymphocytes |
| 11/1/1996 | E-185-1995/0 | 5,939,530 | Inhibitory And Non-Inhibitory Antigen Binding Polypeptides Against Human P450 Enzymes |
| 9/1/1996 | E-002-1993/0 | 5,569,755
5,831,015
6,210,887 | Colon Mucosa Gene Having Down-Regulated Expression In Colon Adenomas And Adenocarcinomas |
| 7/1/1996 | E-094-1994/0 | 7,070,972
7,488,808 | Janus Family Kinases (JAK) And Identification Of Immune Modulators |
| 7/1/1996 | E-044-1991/2 | 6,566,098
7,605,127 | Truncated Hepatocyte Growth Factor Variants |
| 7/1/1996 | E-221-1989/0
E-221-1989/1 | 5,183,884
5,480,968
5,820,859
5,916,755
6,639,060 | Novel Epidermal Growth Factor Receptor (ErbB-3) And Antibodies |
| 4/1/1996 | E-184-1993/0 | 5,518,885
5,654,406 | ERBB2 Promoter Binding Protein In Neoplastic Disease |
| 4/1/1996 | E-029-1990/0
E-029-1990/1 | 5,403,926
5,702,907
5,811,262 | Hepatocellular Carcinoma Oncogene |
| 4/1/1994 | E-116-1992/0 | 5,569,602 | The First Immortalized Kaposi's Sarcoma Cell Line |
| 1/1/1994 | E-253-1993/0 | 5,437,951
5,709,996
5,716,620
5,744,142
5,756,284
5,871,998
5,985,610
7,220,419
7,361,356 | Self-Assembling Recombinant Papillomavirus Capsid Proteins |